Moberg Pharma AB (publ)

kr 10.40As of Sun 8 Nov 2026, 12:00 UTC
STO:MOBHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (30.22%)
Div yield —
ROE (3.22%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.11
PE TTM —
TSR TTM 31.65%
Mkt cap kr 490.7M
ROIC (4.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 13
24.33%
(93.14%)
Hold 1|5|9|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.14
0.14
0.16
0.17
22.70%
7.98%
19.27%
28.05%
Revenuekr M
34.81
36.88
38.92
40.51
3.31%
8.21%
7.94%
14.90%
Peers (US$49.61M)
Cap (US$)
PE
49.92M
13.31x
Capital
TTM
5Y
10Y
Leveragex
2.299
0.110
0.106
EBIT/Intx
1.313
0.186
0.171
Own earn%
97.65
44.47
15.00
Sh yield%
13.03
41.25
38.69
Owners
Insiders/Inst%
4.89
74.44
Short interest%
1.83
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
17